When should the first Tetanus Toxoid (TT) vaccine be given during pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Timing of First Tetanus Toxoid Vaccine in Pregnancy

For pregnant women with unknown or incomplete tetanus vaccination history, the first tetanus toxoid-containing vaccine should be administered as soon as feasible upon recognition of the vaccination gap, regardless of gestational age. 1

Primary Vaccination Series for Unvaccinated or Incompletely Vaccinated Pregnant Women

Women who have never received tetanus vaccination or have incomplete vaccination require a 3-dose primary series:

  • First dose: Administer immediately upon identification, as soon as feasible during pregnancy 1
  • Second dose: At least 4 weeks after the first dose 1
  • Third dose: 6 months after the second dose (may extend to 6-12 months) 1

Td (tetanus-diphtheria) is the preferred vaccine for the primary series during pregnancy. 1 However, providers may substitute a single dose of Tdap for one dose of Td during pregnancy, preferably between 27-36 weeks gestation, and complete the remaining doses with Td. 1

Critical Rationale for Immediate Administration

The urgency of starting vaccination immediately stems from the need to prevent maternal and neonatal tetanus, which carries significant morbidity and mortality risk. 1 Delaying the first dose reduces the likelihood of completing the series before delivery and achieving adequate protective antibody levels (>0.1 IU/mL by ELISA). 1

Timing Considerations by Trimester

While second or third trimester administration is preferred to minimize perception of association with first-trimester adverse pregnancy outcomes (which are more common in the first trimester for unrelated reasons), this preference should not delay necessary vaccination. 1 The key principle is that protection against tetanus takes priority over timing preferences. 1

For Women with Prior Vaccination History

If a pregnant woman has completed the primary tetanus series but the last booster was >10 years ago:

  • Administer Tdap between 27-36 weeks gestation (preferably earlier in this window) 1, 2, 3
  • This timing maximizes maternal antibody response and passive transfer to the infant 2, 3

If the last tetanus-containing vaccine was within the past 10 years:

  • Tdap should still be given at 27-36 weeks gestation during each pregnancy, regardless of prior Tdap history 1, 2, 3

Special Circumstances Requiring Immediate Vaccination

For wound management during pregnancy:

  • If ≥5 years have elapsed since the last tetanus booster, administer Tdap immediately regardless of gestational age 1, 2
  • Do not delay for optimal timing windows when wound prophylaxis is indicated 1, 2

Common Pitfalls to Avoid

  • Do not delay the first dose in unvaccinated pregnant women waiting for the "optimal" trimester—start immediately 1
  • Do not assume vaccination history is complete without documentation; treat uncertain histories as unvaccinated 1
  • Do not skip Tdap during pregnancy even if the woman received it recently outside of pregnancy—each pregnancy requires Tdap at 27-36 weeks 1, 2, 3
  • Do not restart the series if doses are delayed; simply continue from where the patient left off 1, 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Timing of DTaP Vaccination During Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Tetanus Toxoid Administration Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.